BCR and chronic myelogenous leukemia, BCR-ABL1 positive: This means that disease recurrence usually occurs after TKI discontinuation because surviving CML leukemic stem cells (LSCs) are BCR::ABL kinase-independent and insensitive to TKIs [3,4].